Friedrichs GS, Chi L, Park JL, Lucchesi BR
Department of Pharmacology, University of Michigan Medical School, Ann Arbor, Michigan, USA
J Cardiovasc Pharmacol Ther. 1997 Oct;2(4):299-308. doi: 10.1177/107424849700200408.
The present study examined the contributory role of endogenous catecholamines in adenosine-induced ventricular fibrillation in isolation rabbit hearts. METHODS AND RESULTS: Cardiac catecholamine depletion was induced in eleven rabbits by the administration of 6-hydroxydopamine (2 x 30 mg/kg, every 12 hours intramuscularly). Hearts were removed 24 hours later, and subjected to 12 minutes of hypoxic perfusion followed by 40 minutes of reoxygenation while heart rate was maintained with atrial pacing. One of six, and one of five hearts from 6-hydroxydopamine treated rabbits developed ventricular fibrillation during hypoxia-reoxygenation when exposed to 3,7-dimethyl-1-propargylzanthine (DMPX) (10 µM) + adenosine (ADO) (1 µM) and DMPX (10 µM) + ADO (10 µM), respectively. In hearts from a control group, not exposed to 6-hydroxydopamine, ventricular fibrillation developed in each of five (100% incidence) hearts when perfused in the presence of DMPX (10 µM) + ADO (10 µM) (P <.05). Nadolol (1 µM), a beta-adrenoceptor DMPX (10 µM) + ADO (10 µM) treated hearts (n = 6, P <.05 vs DMPX + ADO treated hearts). To ensure catecholamine depletion, spontaneously beating isolated hearts from vehicle and 6-hydroxydopamine treated rabbits were perfused under normoxic conditions while exposed to increasing concentrations of tyramine (1, 3, 10 mM) and the change in heart rate was determined. A concentration-related, positive chronotorpic response to tyramine was obtained in hearts from the vehicle treated group that was absent in hearts from 6-hydroxy-dopamine treated rabbits or hearts perfused in the presence of nadolol. CONCLUSIONS: The results demonstrate that inhibition of the cardiac adenosine A(2) receptor, unmasks an adenosine A(1) receptor profibrillatory effect that is dependent upon endogenous cardiac catecholamines and beta-adrenoreceptor activation during myocardial hypoxia-reoxygenation.
本研究探讨内源性儿茶酚胺在腺苷诱导离体兔心脏室颤中的作用。
通过给予6-羟基多巴胺(2×30mg/kg,每12小时肌肉注射一次)诱导11只家兔心脏儿茶酚胺耗竭。24小时后取出心脏,进行12分钟的缺氧灌注,随后复氧40分钟,同时通过心房起搏维持心率。在缺氧-复氧期间,6-羟基多巴胺处理的家兔心脏中,分别有6只中的1只和5只中的1只在暴露于3,7-二甲基-1-丙炔基黄嘌呤(DMPX)(10μM)+腺苷(ADO)(1μM)和DMPX(10μM)+ADO(10μM)时发生室颤。在未暴露于6-羟基多巴胺的对照组心脏中,当在DMPX(10μM)+ADO(10μM)存在下灌注时,5只心脏中的每只都发生了室颤(发生率100%)(P<.05)。纳多洛尔(1μM),一种β-肾上腺素能受体拮抗剂,可预防DMPX(10μM)+ADO(10μM)处理的心脏发生室颤(n = 6,与DMPX + ADO处理的心脏相比P<.05)。为确保儿茶酚胺耗竭,在常氧条件下对来自给予赋形剂和6-羟基多巴胺处理的家兔的自发搏动离体心脏进行灌注,同时暴露于浓度递增的酪胺(1、3、10mM),并测定心率变化。在给予赋形剂处理组的心脏中获得了对酪胺的浓度依赖性正性变时反应,而在6-羟基多巴胺处理的家兔心脏或在纳多洛尔存在下灌注的心脏中未观察到这种反应。
结果表明,在心肌缺氧-复氧期间,抑制心脏腺苷A(2)受体可揭示一种依赖于内源性心脏儿茶酚胺和β-肾上腺素能受体激活的腺苷A(1)受体促室颤效应。